Posts tagged SAINT
FDA Action Needed: Approval of Maintenance Transcranial Magnetic Stimulation (TMS) for Depression
FDA Action Needed: Approval of Maintenance Transcranial Magnetic Stimulation (TMS) for Depression

Transcranial Magnetic Stimulation (TMS) is one of the safest and most effective treatments for major depression. The FDA has approved it to treat teenagers and adults but only for a time-limited course of care. For most people, that is all the treatment they need. For others, they require maintenance (continuation) TMS. This article reviews the research and rationale that shows the need for the FDA to approve maintenance TMS now.

Read More
AdvocacyLen Lantz, MDThe Psychiatry ResourceDepression, dTMS, iTBS, TMS, rTMS, Medication, Antidepressant, Neuromodulation, Resistant, Treatment, Therapy, Psychiatry, Transcranial Magnetic Stimulation, Adolescent, Teenagers, Child, Children, Kid, Kids, ECT, FDA, Approval, Neuronetics, NeuroStar, Research, Suicide, Insurance, Parity, Mental Health Parity, Mental Health, Theta burst, Maintenance TMS, Maintenance, Acute, Antidepressants, Stanford, SAINT, SNT, Continuation, whyComment